Utama › Kanser Paru-paru Bukan Sel Kecil › California › Mountain View
Kajian klinikal Kanser Paru-paru Bukan Sel Kecil di Mountain View, CA
21 kajian untuk Kanser Paru-paru Bukan Sel Kecil sedang mencari peserta di lokasi dalam dan sekitar Mountain View (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Stanford Cancer Institute (Melanoma/NSCLC), Stanford · 5 mi jauh
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Mengambil pesertaFasa 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mi jauh
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi jauh
Adaptive ctDNA-Based Personalization of Treatment During Consolidation Therapy in NSCLC
Mengambil pesertaFasa 3
- Stanford University, Stanford · 5 mi jauh
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Mengambil pesertaFasa 2
- Stanford Cancer Institute, Stanford · 5 mi jauh
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Mengambil pesertaKajian pemerhatian
- Stanford University, Palo Alto · 5 mi jauh
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Mengambil pesertaFasa 2
- Stanford Cancer Institute, Stanford · 5 mi jauh
- Stanford Hospital and Clinics, Stanford · 5 mi jauh
- Stanford Hospital Investigational Drug Services, Stanford · 5 mi jauh
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Stanford Cancer Center, Palo Alto · 5 mi jauh
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Mengambil pesertaFasa 1/2
- Stanford Cancer Institute, Stanford · 5 mi jauh
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
Mengambil pesertaFasa 1/2
- Stanford University Medical Center - Neurology, Stanford · 5 mi jauh
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Palo Alto Medical Foundation Research Center, Palo Alto · 5 mi jauh
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
Mengambil pesertaFasa 1/2
- Stanford Cancer Institute, Stanford · 5 mi jauh
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Mengambil pesertaFasa 1/2
- Stanford University Medical Center, Stanford · 5 mi jauh
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Mengambil pesertaFasa 1
- Stanford University Medical Center, Palo Alto · 5 mi jauh
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Mengambil pesertaFasa 1
- Stanford University, Palo Alto · 5 mi jauh
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Mengambil pesertaFasa 1/2
- Stanford University - Stanford Cancer Institute, Stanford · 5 mi jauh
A Study of LY4175408 in Participants With Advanced Cancer
Mengambil pesertaFasa 1
- Stanford Medicine Cancer Center, Stanford · 5 mi jauh
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Mengambil pesertaFasa 1/2
- Stanford University, Stanford · 5 mi jauh
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Mengambil pesertaFasa 1/2
- Stanford Women's Cancer Center, Palo Alto · 5 mi jauh
Engagement of Veterans With Lung Cancer
Mengambil peserta
- Veterans Affairs Palo Alto Health Care System (VAPAHCS), Palo Alto · 5 mi jauh
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Stanford · 5 mi jauh
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Mengambil pesertaFasa 1
- Stanford University, Stanford · 5 mi jauh
Kajian Kanser Paru-paru Bukan Sel Kecil di bandar lain
- Houston, TX145 kajian
- New York City, NY121 kajian
- Arlington, VA104 kajian
- Nashville, TN97 kajian
- Boston, MA90 kajian
- Los Angeles, CA87 kajian
- St. Louis, MO73 kajian
- Chicago, IL61 kajian
- Baltimore, MD60 kajian
- San Antonio, TX59 kajian
- Columbus, OH57 kajian
- Washington, DC55 kajian
Kajian lain di Mountain View
- Kanser (semua jenis)40 kajian
- Kanser Payudara26 kajian
- Kanser Metastatik25 kajian
- Leukemia Mieloid Akut19 kajian
- Kanser Ovari19 kajian
- Gangguan Spektrum Autisme17 kajian
- Kanser Paru-paru17 kajian
- Kanser Prostat15 kajian
- Kegagalan Jantung15 kajian
- Autisme13 kajian
- Leukemia Limfoblastik Akut13 kajian
- Kanser Kolorektal13 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.